Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis

American Heart Journal

Volumn 142, Issue 6, 2001, Pages 934-944

  Kim, Catherine ^a   Kwok, Yeong S ^b   Heagerty, Patrick ^a   Redberg, Rita ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; EXERCISE TEST; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; META ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0035206573     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.119761     Document Type: Article

References (119)

1. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance
2. Meta-analysis of exercise testing to detect coronary artery disease in women
3. The comparable diagnostic accuracies of dobutamine-stress and dipyridamole-stress echocardiographies: A meta-analysis
4. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina)
5. Guidelines for meta-analyses evaluating diagnostic tests
6. Combining independent studies of a diagnostic test into a summary ROC curve: Data-analytic approaches and some additional considerations
7. The behavior of maximum likelihood estimates under nonstandard conditions
8. Results of adenosine single photon emission computed tomography thallium-201 imaging in hemodynamic nonresponders
9. Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress
10. Assessment of left ventricular wall motion in angina pectoris by two-dimensional echocardiography and myocardial perfusion by technetium-99m sestamibi tomography during adenosine-induced coronary vasodilation and comparison with coronary angiography
11. Usefulness of hemodynamic changes during adenosine infusion in predicting the diagnostic accuracy of adenosine technetium-99m sestamibi single-photon emission computed tomography (SPECT)
12. Echocardiographic detection of the extent of coronary artery disease in the elderly using dobutamine and adenosine infusion
13. Stress echocardiography in elderly patients with coronary artery disease
14. Use of oral dipyridamole SPECT thallium-201 imaging in detection of coronary artery disease
15. Integrated evaluation of relation between coronary lesion features and stress echocardiography results: The importance of coronary lesion morphology
16. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block by dipyridamole
17. The importance of work-up (verification) bias correction in assessing the accuracy of SPECT thallium-201 testing for the diagnosis of coronary artery disease
18. Dobutamine digital echocardiography for detecting coronary artery disease
19. Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease
20. Stress echocardiography: Comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease
21. Electrocardiographic response during dobutamine stress echocardiography
22. Thallium-201 single photon emission computed tomography with intravenous dipyridamole to diagnose coronary artery disease
23. Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease
24. The value of dobutamine stress echocardiography for the detection of coronary artery disease in women
25. High dose adenosine stress echocardiography for noninvasive detection of coronary artery disease
26. Comparison of exercise and adenosine technetium-99m sestamibi myocardial scintigraphy for diagnosis of coronary artery disease in patient with left bundle branch block
27. Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity
28. Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease
29. Dobutamine stress echocardiogrophy: Initial experience of a Canadian center
30. Dipyridamole echocardiography as a useful and safe test in the assessment of coronary artery disease in the elderly
31. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease
32. Comparison of thallium-201 single-photon emission computed tomographic scintigraphy with intravenous dipyridamole and arm exercise
33. Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography
34. Evaluation and clinical use of early washout ratio of thallium-201 in normal and ischemic myocardium after dipyridamole-induced vasocilation using ring-type emission computed tomography
35. Dobutamine stress echocardiography in the detection of coronary artery disease in a clinical practice setting
36. Localizing individual coronary artery obstructions with the dobutamine stress echocardiography
37. Dobutamine stress echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease
38. Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogram for identification of coronary artery disease
39. Do beta-blockers affect the diagnostic sensitivity of dobutamine stress thallium-201 single photon emission computed tomographic imaging?
40. Simultaneous dobutamine stress echocardiography and thallium-201 perfusion imaging for the detection of coronary artery disease
41. Detection of coronary artery disease by dipyridamole thallium tomography in mitral valve stenosis
42. Vasodilator myocardial perfusion imaging: Demonstration of local electrophysiological changes of ischaemia
43. Intravenous adenosine versus exercise in the noninvasive assessment of coronary artery disease by SPECT
44. Oral vs intravenous dipyridamole echocardiography for detecting coronary artery disease
45. Dobutamine stress echocardiography in women with chest pain
46. Usefulness of dipyridamole-handgrip echocardiography test for detecting coronary artery disease
47. Detection of coronary artery disease by digital stress echocardiography: Comparison of exercise, transesophageal atrial pacing and dipyridamole echocardiography
48. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease
49. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy, or both?
50. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion
51. Comparative ability of dobutamine and exercise stress in inducing myocardial ischaemia in active patients
52. Uses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease
53. Dobutamine stress echocardiography for detection and assessment of coronary artery disease
54. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography
55. Usefulness of single-photon emission computed tomography of thallium-201 uptake after dipyridamole infusion for detection of coronary artery disease
56. Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease
57. The comparative safety and diagnostic accuracy of adenosine myocardial perfusion imaging in women versus men
58. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: Comparison with dobutamine stress echocardiography
59. Quantitative thalium2-1 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease
60. Correlation between hemodynamic changes and tomographic sestamibi imaging during dipyridamole-induced coronary hyperemia
61. Dipyridamole-dobutamine echocardiography: A novel test for the detection of milder former of coronary artery disease
62. Dipyridamole magnetic resonance imaging: A comparison with thallium-201 emission tomography
63. Thallium myocardial perfusion tomography using intravenous dipyridamole combined with maximal dynamic exercise
64. Dobutamine thallium myocardial perfusion tomography
65. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography
66. Comparison of the high-dose dipyridamole-echocardiography test and exercise two-dimensional echocardiography for diagnosis of coronary artery disease
67. The atropine factor in pharmacologic stress echocardiography
68. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease
69. Diagnostic value of dobutamine stress echocardiography in coronary artery disease
70. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: A comparison between dobutamine and dipyridamole
71. Selection of the optimal stress test for the diagnosis of coronary artery disease
72. Dipyridamole and dobutamine-atropine stress echocordiography in the diagnosis of coronary artery disease
73. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease
74. Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain
75. Dobutamine stress echocardiography: Correlation with coronary lesion severity as determined by quantitative angiography
76. Value of dobutamine stress echocardiography for the detection of multivessel coronary artery disease
77. Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease
78. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease
79. Physiological assessment of sensitivity of noninvasive testing for coronary artery disease
80. Feasibility of simultaneous Tc99m sestamibi and 2D-echo cardiac imaging during dobutamine pharmacologic stress
81. Dobutamine and dipyridamole stress echocardiography in patients with a low incidence of severe coronary artery disease
82. Inotropic stress with arbutamine is superior to vasodilator stress with dipyridamole for the detection of reversible ischemia with Tc-99m sestamibi single-photon emission computed tomography
83. Comparison of dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography for detecting coronary artery disease
84. Comparative diagnostic value of dobutamine stress echocardiography and stress thallium-201 single-photon-emission computed tomography for detecting coronary artery disease
85. Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: Comparison with thallium-201 stress-rest study
86. On-line quantitative assessment of left ventricular filling during dobutamine stress echocardiography: A useful addition to conventional wall motion scoring
87. Assessment of thallium scintigraphy and echocardiography during dobutamine infusion for the detection of coronary artery disease
88. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy
89. Diagnosis of ischemic heart disease with adenosine echocardiography
90. Significance of ST segment depression during adenosine-induced coronary hyperemia in angina pectoris and correlation with angiographic, scintigraphic, hemodynamic, and echocardiographic variables
91. Diagnosis of coronary artery disease in elderly patients: Safety and efficacy of dobutamine echocardiography
92. Stress echocardiography in the detection of myocardial ischemia
93. Simultaneous dobutamine stress echocardiography and dobutamine scintigraphy (99mTc-MIVI-SPET) for assessment of coronary disease
94. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy
95. Optimal pharmacological stress testing for the diagnosis of coronary artery disease: A probabilistic approach
96. Evaluation of patients with diabetes mellitus for coronary artery disease using dobutamine stress echocardiography
97. Comparison of dobutamine stress echocardiography and treadmill exercise electrocardiography for detection of coronary artery disease
98. Assessment of the coronary artery disease and systolic dysfunction in hypertensive patients with the dobutamine-atropine stress echocardiography: Effect of the left ventricular hypertrophy
99. Dobutamine stress echocardiography compared with exercise-thallium 201 single-photon emission computed tomography in detecting coronary artery disease-effect of exercise level on accuracy
100. Identification of high-risk patients with left main and three-vessel coronary artery disease by adenosine-single photon emission computed tomographic thallium imaging
101. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease?
102. Myocardial perfusion imaging with positron emission tomography and single photon emission computed tomography: Frequency and causes of disparate results
103. High dose dipyridamole-echocardiography test in women: Correlation with exercise-electrocardiography test and coronary arteriography
104. Implication of the negative U wave during dobutamine stress echocardiography
105. Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography
106. Effect of intravenous adenosine infusion on myocardial perfusion and function
107. Role of dipyridamole-echocardiography test in electrocardiographically silent effort myocardial ischemia
108. Different degrees of ischemic threshold stratified by the dipyridamole-echocardiography test
109. High dose dipyridamole echocardiography test in effort angina pectoris
110. Dipyridamole-echocardiography test in effort angina pectoris
111. Dobutamine versus dipyridamole echocardiography in coronary artery disease
112. Dobutamine stress echocardiography: Its role in the diagnosis of coronary artery disease
113. Echocardiographic detection of coronary artery disease during dobutamine infusion
114. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients
115. Thallium-201 myocardial imaging during pharmacologic coronary vasodilation: Comparison of oral and intravenous administration of dipyridamole
116. Dobutamine stress echocardiography for detecting coronary artery disease
117. Stress echocardiography and the human factor: The importance of being expert
118. Sex and test verification bias: Impact on the diagnostic value of exercise echocardiography